Cytosorbents Corp Files 8-K
Ticker: CTSO · Form: 8-K · Filed: Apr 17, 2025 · CIK: 1175151
| Field | Detail |
|---|---|
| Company | Cytosorbents CORP (CTSO) |
| Form Type | 8-K |
| Filed Date | Apr 17, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, filing
TL;DR
CYTOSORBENTS FILED AN 8-K. NO MAJOR NEWS, JUST STANDARD REPORTING.
AI Summary
Cytosorbents Corporation filed an 8-K on April 17, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or new material events beyond the standard reporting requirements.
Why It Matters
This filing indicates routine corporate reporting, providing transparency to investors about the company's regulatory compliance and financial disclosures.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for disclosures and exhibits, not indicating any new risks or significant events.
Key Players & Entities
- Cytosorbents Corporation (company) — Registrant
- April 17, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 001-36792 (commission_file_number) — SEC File Number
- 98-0373793 (ein) — I.R.S. Employer Identification No.
- 305 College Road East Princeton, New Jersey 08540 (address) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to provide Financial Statements and Exhibits.
What is the exact name of the registrant?
The exact name of the registrant is CYTOSORBENTS CORPORATION.
In which state was Cytosorbents Corporation incorporated?
Cytosorbents Corporation was incorporated in Delaware.
What is the SEC file number for Cytosorbents Corporation?
The SEC file number for Cytosorbents Corporation is 001-36792.
What is the address of Cytosorbents Corporation's principal executive offices?
The address of Cytosorbents Corporation's principal executive offices is 305 College Road East, Princeton, New Jersey 08540.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 17, 2025 regarding Cytosorbents Corp (CTSO).